SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-106450
Filing Date
2014-03-19
Accepted
2014-03-19 16:17:00
Documents
4
Period of Report
2014-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d694990d8k.htm 8-K 23564
2 EX-10.1 d694990dex101.htm EX-10.1 184364
3 EX-99.1 d694990dex991.htm EX-99.1 11341
4 GRAPHIC g694990g63l92.jpg GRAPHIC 25968
  Complete submission text file 0001193125-14-106450.txt   256335
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36070 | Film No.: 14704117
SIC: 2834 Pharmaceutical Preparations